Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AMX0035
AMX0035
Amylyx completes subject enrollment in ALS therapy trial
Clinical Trials Arena
Fri, 02/3/23 - 10:33 am
Amylyx
clinical trials
AMX0035
ALS
Highlighted by Amylyx, the ALS Space is Gaining Momentum
BioSpace
Fri, 09/9/22 - 11:11 am
ALS
AMX0035
Amylyx
GeNeuro
NeuroSense Therapeutics
BrainStorm Cell Therapeutics
FDA advisers back Amylyx ALS drug, reversing earlier position
BioPharma Dive
Thu, 09/8/22 - 12:00 am
Amylyx
FDA
ALS
AMX0035
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
FDA
Bristol Myers Squibb
deucravacitinib
Amylyx Pharmaceuticals
ALS
AMX0035
Ferring Pharmaceuticals
microbiome
RBX2660
Revance Therapeutics
Bluebird Bio
Spectrum Pharmaceuticals
JNJ
Oncopeptides
FDA to reconvene experts' meeting for Amylyx ALS drug
Yahoo/Reuters
Tue, 07/5/22 - 10:48 am
Amylyx
ALS
FDA
AMX0035
Go or no go? The FDA’s Amylyx dilemma
EP Vantage
Tue, 05/31/22 - 10:29 am
FDA
Amylyx
AMX0035
ALS
COVID-19
vaccines
Novavax
Moderna Therapeutics
Pfizer
Acadia Pharma
Bluebird Bio
Amylyx Augments Case for ALS Drug Ahead of PDUFA Date
BioSpace
Thu, 05/5/22 - 11:30 pm
Amylx
AMX0035
ALS
FDA
An FDA panel reviewing Amylyx's ALS drug was moved by patient testimony—but they voted it down anyway
Fierce Biotech
Thu, 03/31/22 - 10:48 am
Amylyx
ALS
FDA
patients
AMX0035
Amylyx faces an uphill battle
EP Vantage
Wed, 03/30/22 - 10:42 am
Amylyx
FDA
AMX0035
Go or no go? Bristol’s Lag3 debut
EP Vantage
Fri, 02/25/22 - 10:21 am
Bristol Myers Squibb
relatlimab
FDA
AMX0035
Amylx
Amylyx, faced with longer FDA path for promising ALS drug, gets major cash infusion
BioPharma Dive
Tue, 07/20/21 - 12:31 pm
Amylyx Pharmaceuticals
ALS
venture capital
FDA
AMX0035
FDA faces backlash after seeking more data on an experimental ALS therapy
BioPharma Dive
Wed, 04/14/21 - 09:53 pm
ALS
AMX0035
Amylyx Pharmaceuticals
FDA
Early signs of survival benefit raise optimism around a small biotech's ALS drug
BioPharma Dive
Sun, 10/18/20 - 12:03 am
ALS
AMX0035
Amylyx Pharmaceuticals
After a rare win, a biotech details long-awaited results for its ALS drug
BioPharma Dive
Wed, 09/2/20 - 07:54 pm
ALS
AMX0035
Amylyx
FDA